Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial.
Johansen NJ, Dejgaard TF, Lund A, Schlüntz C, Frandsen CS, Forman JL, Wewer Albrechtsen NJ, Holst JJ, Pedersen-Bjergaard U, Madsbad S, Vilsbøll T, Andersen HU, Knop FK. Johansen NJ, et al. Among authors: schluntz c. Lancet Diabetes Endocrinol. 2020 Apr;8(4):313-324. doi: 10.1016/S2213-8587(20)30030-9. Epub 2020 Mar 2. Lancet Diabetes Endocrinol. 2020. PMID: 32135138 Clinical Trial.
Effect of short-acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double-blind placebo-controlled trial.
Johansen NJ, Dejgaard TF, Lund A, Schlüntz C, Larsen EL, Poulsen HE, Goetze JP, Møller HJ, Vilsbøll T, Andersen HU, Knop FK. Johansen NJ, et al. Among authors: schluntz c. Diabetes Obes Metab. 2020 Sep;22(9):1639-1647. doi: 10.1111/dom.14078. Epub 2020 Jun 16. Diabetes Obes Metab. 2020. PMID: 32543021 Clinical Trial.